Clinical trial with lozenges as local anesthesia for allogeneic bone marrow transplant patients with oral mucositis
Phase of Trial: Phase II
Latest Information Update: 22 Aug 2016
At a glance
- Drugs Bupivacaine (Primary)
- Indications Inflammatory pain
- Focus Therapeutic Use
- Acronyms OMBMT Lozenge
- 16 Aug 2016 Status changed from completed to discontinued.
- 04 Aug 2016 Status changed from recruiting to completed.
- 02 Jun 2013 New trial record